NHS Genomic Medicine Service - Most Suitable Provider Process
Buyers
Value
£36,225,000,000
Suppliers
- Manchester University NHS Foundation Trust
- The Newcastle upon Tyne Hospitals NHS Foundation Trust
- Birmingham Women’s and Children’s NHS Foundation Trust
- Cambridge University Hospitals NHS Foundation Trust
- NORTH BRISTOL NHS TRUST
- Great Ormond Street Hospital for Children NHS Foundation Trust
- Guy's and St Thomas' NHS Foundation Trust
Classifications
- Health services
Tags
- award
- contract
Published
1 day ago
Description
This is a notice of intention to make an award in respect of the NHS Genomic Medicine Service pursuant to the Most Suitable Provider (MSP) Process for the NHS Genomic Medicine Service (NHS GMS). For the avoidance of doubt, this is an intention to award notice. A notice of the confirmation of the award of each contract will be issued once they are signed.<br/><br/>Pursuant to the NHS GMS contracts, provider are to provide the following functions: <br/>• Organisational leadership, governance and partnership arrangements;<br/>• Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>• Laboratory operating model;<br/>• Clinical function: cancer genomics;<br/>• Clinical function: rare disease;<br/>• Clinical function: population health;<br/>• Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>• Transformation and Service Improvement;<br/>• People – workforce, education and training; and<br/>• Data and digital
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete